Prosecution Insights
Last updated: October 27, 2026

Elizabeth Bisola Oguntade, USPTO Patent Examiner

Listed by the USPTO as OGUNTADE, ELIZABETH BISOLA

Tech Center 2800 • Art Units: 1600 1654 1677 1678 2818

This examiner grants 50% of resolved cases

Analysis

OGUNTADE, ELIZABETH BISOLA has resolved 2 cases in Tech Center 2800 and Art Unit 1600. The allowance rate is 50.0%, the interview lift is 100.0%, and the median time to allowance is 872 days. The interview lift exceeds the allowance rate, but the record contains only 2 resolved cases. That limited volume makes the figures useful as an early signal rather than a stable predictor.

The principal companies are Howard Hughes Medical Institute, Sheba Impact Ltd., and The Johns Hopkins University. The leading firms are BIRCH STEWART KOLASCH & BIRCH, LLP, Alford Law Group, Inc., and Anova Law Group, PLLC. Counsel should consider the strong interview association alongside the small case base when developing expectations for future matters.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

50.0%
Allow Rate
-18.0% vs TC avg
43
Total Applications
+100.0%
Interview Lift
872
Avg Prosecution Days
Based on 2 resolved cases, 2023–2026

Rejection Statute Breakdown

10.7%
§101 Eligibility
12.5%
§102 Novelty
35.1%
§103 Obviousness
31.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18575591 METHODS OF DETERMINING RISK OF AND TREATING CANCER RECURRENCE Non-Final OA THE REGENTS OF THE UNIVERSITY OF MICHIGAN
17630104 METHODS AND COMPOSITIONS FOR HEPATITIS C VIRUS (HCV) Non-Final OA The Johns Hopkins University
18700260 DHEAS ASSAY, REAGENTS FOR SAME, AND METHODS OF PRODUCTION AND USE THEREOF Non-Final OA Siemens Healthcare Diagnostics Inc.
18574221 MIGRATION OF HUMAN PERIPHERAL LEUKOCYTES IN RESPONSE TO CHEMOTACTIC FACTORS DURING PREGNACY Non-Final OA The Governors of the University of Alberta
18681989 DETECTION OF BIOACTIVE AGENTS IN A SURROUNDING MEDIUM Non-Final OA Philip Morris Products S.A.
18608596 POLYMER-COATED GLASS SUBSTRATE Non-Final OA SUMITOMO RUBBER INDUSTRIES, LTD.
18833026 METHOD FOR DETERMINATION OF MUTATED FORM OF MUCIN-1 PROTEIN IN A BIOLOGICAL SAMPLE Non-Final OA WAKE FOREST UNIVERSITY HEALTH SCIENCES
18575743 Affinity ligands for the purification and detection of ubiquitin muteins Non-Final OA Navigo Proteins GmbH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Elizabeth Bisola Oguntade's allowance rate?

50.0% of resolved applications examined by Elizabeth Bisola Oguntade were allowed (2 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.

Does an interview help with examiner Elizabeth Bisola Oguntade?

This examiner's interview lift is +100.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Elizabeth Bisola Oguntade take to allow a patent?

Applications allowed by Elizabeth Bisola Oguntade took 872 days on average from filing to allowance.

Which art unit does examiner Elizabeth Bisola Oguntade work in?

Elizabeth Bisola Oguntade examines applications in Art Unit 1600 in Tech Center 2800 (Semiconductors, Circuits & Optics).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month